心脉医疗
(688016)
| 流通市值：126.70亿 | | | 总市值：126.70亿 |
| 流通股本：1.23亿 | | | 总股本：1.23亿 |
| 报告期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 787,174,656.18 | 358,081,405.15 | 1,187,204,459.56 | 888,459,839.37 |
| 营业收入 | 787,174,656.18 | 358,081,405.15 | 1,187,204,459.56 | 888,459,839.37 |
| 二、营业总成本 | 323,455,886.28 | 145,767,427.87 | 641,267,223.89 | 453,371,586.13 |
| 营业成本 | 184,417,127.73 | 84,093,698.7 | 279,577,994.84 | 205,588,824.94 |
| 税金及附加 | 8,236,853.67 | 3,662,271.82 | 12,032,019.57 | 9,090,277 |
| 销售费用 | 62,389,783 | 26,583,495.65 | 130,156,250.56 | 89,121,847.65 |
| 管理费用 | 28,319,058.82 | 12,594,236.71 | 55,030,462.74 | 38,828,204.69 |
| 研发费用 | 48,673,142.99 | 23,190,117.2 | 172,884,268.43 | 117,766,098.67 |
| 财务费用 | -8,580,079.93 | -4,356,392.21 | -8,413,772.25 | -7,023,666.82 |
| 其中:利息费用 | 832,596.11 | 443,130.69 | 1,821,925.57 | 1,438,997.48 |
| 其中:利息收入 | 9,266,687.77 | 4,634,160.01 | 9,261,266.14 | 7,263,239.16 |
| 加:投资收益 | 16,457,857.09 | 7,127,681.04 | 9,148,489.85 | 5,850,521.95 |
| 资产减值损失(新) | -2,101,578.71 | -1,741,164.06 | -6,354,297.12 | -3,703,581.94 |
| 信用减值损失(新) | -10,025,162.37 | -2,329,613.74 | -1,336,190.64 | -3,063,482.69 |
| 其他收益 | 4,691,353.76 | 2,396,063.5 | 26,459,104.81 | 19,050,770.06 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 472,741,239.67 | 217,766,944.02 | 573,854,342.57 | 453,222,480.62 |
| 加:营业外收入 | 61,475.06 | 54,362.95 | 334,557.66 | 240,877.09 |
| 减:营业外支出 | 1,647,476.59 | 1,060,608.94 | 1,921,912.31 | 1,662,823.26 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 471,155,238.14 | 216,760,698.03 | 572,266,987.92 | 451,800,534.45 |
| 减:所得税费用 | 71,574,584.17 | 33,894,586.82 | 85,050,009.75 | 66,947,965.65 |
| 六、净利润 | 399,580,653.97 | 182,866,111.21 | 487,216,978.17 | 384,852,568.8 |
| 持续经营净利润 | 399,580,653.97 | 182,866,111.21 | 487,216,978.17 | 384,852,568.8 |
| 归属于母公司股东的净利润 | 403,523,612.05 | 184,296,095.55 | 492,431,974.71 | 388,426,350.58 |
| 少数股东损益 | -3,942,958.08 | -1,429,984.34 | -5,214,996.54 | -3,573,781.78 |
| (一)基本每股收益 | 3.27 | 2.23 | 6.81 | 5.4 |
| (二)稀释每股收益 | 3.27 | 2.23 | 6.81 | 5.4 |
| 八、其他综合收益 | 57,363.55 | -35,100.64 | -396,770.24 | -387,055.45 |
| 归属于母公司股东的其他综合收益 | 57,363.55 | -35,100.64 | -396,770.24 | -387,055.45 |
| 九、综合收益总额 | 399,638,017.52 | 182,831,010.57 | 486,820,207.93 | 384,465,513.35 |
| 归属于母公司股东的综合收益总额 | 403,580,975.6 | 184,260,994.91 | 492,035,204.47 | 388,039,295.13 |
| 归属于少数股东的综合收益总额 | -3,942,958.08 | -1,429,984.34 | -5,214,996.54 | -3,573,781.78 |
| 公告日期 | 2024-08-27 | 2024-04-27 | 2024-03-28 | 2023-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |